Publications by authors named "Mingting Ye"
Eur J Med Res
August 2023
Article Synopsis
- The study aimed to assess the effectiveness and safety of osimertinib for treating leptomeningeal metastases in patients with EGFR-mutant non-small cell lung cancer (NSCLC).
- Researchers conducted a systematic review and meta-analysis of 11 studies involving 353 patients, evaluating response rates, overall survival, and side effects.
- Results showed a 42% overall response rate and a 59% one-year survival rate, with manageable side effects like rash and diarrhea occurring in significant percentages.
